Samsara Opportunity Fund GP, LLC

Historique de performance de Samsara Opportunity Fund GP, LLC

Historique insuffisant pour un historique de performance statistique (moins de 5 achats sur le marché).

Historique des transactions de Samsara Opportunity Fund GP, LLC

Co-initiés de Samsara Opportunity Fund GP, LLC

• ADAMIS ANTHONY PKalaris Therapeutics, Inc.
• Adams Derek N.Kalaris Therapeutics, Inc.
• AKKARAJU SRINIVASKalaris Therapeutics, Inc.
• Atillasoy ErcemKalaris Therapeutics, Inc.
• Bayko Liisa AnnKalaris Therapeutics, Inc.
• Bornstein Jeffrey SKalaris Therapeutics, Inc.
• Brainard DianaKalaris Therapeutics, Inc.
• Brenner MalcolmKalaris Therapeutics, Inc.
• Dybbs MichaelKalaris Therapeutics, Inc.
• ElevateBio, LLCKalaris Therapeutics, Inc.
• F2 Bioscience AV 2022 LLCKalaris Therapeutics, Inc.
• F2 Capital I 2020Kalaris Therapeutics, Inc.
• F2 MC, LLCKalaris Therapeutics, Inc.
• F2 MG LtdKalaris Therapeutics, Inc.
• F2 - TPO Investments LLCKalaris Therapeutics, Inc.
• Feinsod MatthewKalaris Therapeutics, Inc.
• Ferrara NapoleoneKalaris Therapeutics, Inc.
• GADICKE ANSBERTKalaris Therapeutics, Inc.
• Gall MatthewKalaris Therapeutics, Inc.
• GILEAD SCIENCES INCKalaris Therapeutics, Inc.
• Globeways Holdings II LtdKalaris Therapeutics, Inc.
• Globeways Holdings LtdKalaris Therapeutics, Inc.
• Green JeremyKalaris Therapeutics, Inc.
• Hagen Brett RKalaris Therapeutics, Inc.
• Hallal DavidKalaris Therapeutics, Inc.
• Jovan-Embiricos MoranaKalaris Therapeutics, Inc.
• Leen Ann M.Kalaris Therapeutics, Inc.
• Melian AgustinKalaris Therapeutics, Inc.
• Miller EdwardKalaris Therapeutics, Inc.
• Oxtoby AndrewKalaris Therapeutics, Inc.
• PATEL SAMIR CHANDRAKANTKalaris Therapeutics, Inc.
• PATTERSON LEONE DKalaris Therapeutics, Inc.
• Piccina CintiaKalaris Therapeutics, Inc.
• Redmile Group, LLCKalaris Therapeutics, Inc.
• Samsara BioCapital GP, LLCKalaris Therapeutics, Inc.
• Samsara BioCapital, L.P.Kalaris Therapeutics, Inc.
• Samsara Opportunity Fund, L.P.Kalaris Therapeutics, Inc.
• Sinha VikasKalaris Therapeutics, Inc.